Skip to main content
. 2018 Oct 21;94(1):118–132. doi: 10.1002/ajh.25301

Figure 4.

Figure 4

Rescue therapy use in trials of eltrombopag, rituximab, or romiplostim. Calculated rate ratios comparing the rate of rescue therapy use among patients receiving eltrombopag, rituximab, or romiplostim vs that in patients receiving placebo or standard of care